CRESTONE e Clinical Study of REsponse to Seribantumab in Tumors with NEuregulin-1 (NRG1) Fusions e A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)
Meeting Abstract
Spigel, D.; Waqar, S. N.; Burkard, M. E.; Lin, J. J.; Chae, Y. K.; Socinski, M. A.; Gadgeel, S.; Reckamp, K. L.; Leland, S. M.; Plessinger, D.; Kunkel, L.; Bauman, J. R.; Otterson, G.; Halmos, B.; Ou, S. -H. Ignatius; Patil, T.; Elamin, Y. Y.; Kim, E. S.